- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | VITURA HEALTH LIMITED: Release of shares from escrow | - | ASX | ||
| 05.04. | VITURA HEALTH LIMITED: Local manufacture of MDMA | 1 | ASX | ||
| 18.03. | Australia's Vitura Health jumps on first supply of therapeutic 'magic' mushrooms | - | Reuters | ||
| 17.03. | VITURA HEALTH LIMITED: First supply of Psilocybin | 1 | ASX | ||
| 15.03. | Dr Boreham's Crucible: Vitura Health is the tall poppy in a paddock of weed | 1 | Stockhead | ||
| 28.02. | VITURA HEALTH LIMITED: Change in substantial holding | 1 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: Investor webinar and presentation | - | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: Half Yearly Report and Accounts | - | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: ASX Appendix 4D | - | ASX | ||
| 11.02. | VITURA HEALTH LIMITED: Initial Director's Interest Notice | - | ASX | ||
| 11.02. | VITURA HEALTH LIMITED: Appointment of Independent Chair | - | ASX | ||
| 22.01. | VITURA HEALTH LIMITED: Agreement executed with WholeLife Pharmacy Group | 1 | ASX | ||
| 09.01. | Canberra is making vapes prescription-only and Vitura Health is going to provide them | 1 | The Market Herald Australia | ||
| 09.01. | VITURA HEALTH LIMITED: Vitura adds smoking cessation product vertical | 1 | ASX | ||
| 27.12.23 | Australia's Vitura Health tumbles on loss of software license | 1 | Reuters | ||
| 27.12.23 | VITURA HEALTH LIMITED: Canview Services Agreement not to be extended | 1 | ASX | ||
| 15.12.23 | VITURA HEALTH LIMITED: Change of Director's Interest Notice | 1 | ASX | ||
| 15.12.23 | VITURA HEALTH LIMITED: Notification regarding unquoted securities - VIT | 1 | ASX | ||
| 15.12.23 | VITURA HEALTH LIMITED: Notification regarding unquoted securities - VIT | 1 | ASX | ||
| 10.12.23 | VITURA HEALTH LIMITED: Sale of 2 millionth unit through CanView | - | ASX |
Seite:
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 6,125 | -0,24 % | Canopy Growth, Aurora climb amid SAFER Banking Act push | ||
| TILRAY BRANDS | 1,629 | +0,52 % | Cannabis-Aktien: Cannabis-Rally zerfällt zu Staub. Tilray und Canopy im Fokus. | Anzeige / WerbungDer Erwartungen waren hoch. Die Enttäuschung ist nun mindestens genauso groß.Der Erwartungen waren hoch. Die Enttäuschung ist nun mindestens genauso groß. Der Start in die Berichtssaison... ► Artikel lesen | |
| BEVCANNA ENTERPRISES | 1,320 | -0,38 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 23.02.2024 | The following instruments on XETRA do have their first trading 23.02.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 23.02.2024
Aktien
1 CA28655A1066 Eli Lilly and Company... ► Artikel lesen | |
| ORGANIGRAM | 1,766 | +0,80 % | 50 - 200 % * X mit Cannabis Aktien? Aurora, Tilray, Organigram, Planet 13, High Tide, Village Farms | Sind Sie daran interessiert, in Cannabis-Aktien zu investieren, und fragen Sie sich nach den möglichen Renditen? In diesem Kommentar besprechen wir die Möglichkeit, mit Unternehmen wie Aurora Cannabis... ► Artikel lesen | |
| MYDECINE INNOVATIONS GROUP | 0,017 | -31,25 % | Mydecine Innovations Group Inc - Closing of Share for Debt Settlement | Mydecine Innovations Group Inc - Closing of Share for Debt Settlement
PR Newswire
LONDON, United Kingdom, April 16
MYDECINE INNOVATIONS GROUP INC.ANNOUNCES CLOSING OF... ► Artikel lesen | |
| SNDL | 1,716 | -0,46 % | SNDL, Arcadia Biosciences among Consumer Staples movers | ||
| BIONANO GENOMICS | 0,782 | -4,19 % | Bionano Genomics: Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing | SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 0,155 | 0,00 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights | Positive results from confirmatory Phase 3 RESILIENT study reported in December 2023 position Tonmya for fibromyalgia for NDA submission second half of 2024; pre-NDA meeting with FDA scheduled for... ► Artikel lesen | |
| HIGH TIDE | 2,055 | -1,44 % | High Tide kündigt Wechsel des Chief Financial Officer an | Bei dieser Pressemitteilung handelt es sich um eine "designierte Pressemitteilung", die im Hinblick auf den Prospektnachtrag des Unternehmens
vom 31. August 2023 zu seinem Kurzprospekt vom 3.... ► Artikel lesen | |
| YOURWAY CANNABIS BRANDS | - | - | YourWay Cannabis Brands Inc.: YourWay Cannabis Brands Announces Termination of Agreement to Sell Labtronix | Phoenix, Arizona and Vancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - YourWay Cannabis Brands Inc. (CSE: YOUR) (OTC: YOURF) ("YourWay" or the "Company") announced today that effective... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 4,230 | -1,05 % | Jones starts Achieve Life Sciences at buy, cites market opportunity | ||
| JAGUAR HEALTH | 0,162 | -2,70 % | Jaguar Health, Inc.: Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care | Catherine Miller Collis was instrumental in bringing about Jaguar's recent in-license agreement for FDA-approved Gelclair®, a protective gel for management of oral mucositis, a common, painful, and... ► Artikel lesen | |
| SEELOS THERAPEUTICS | 1,060 | 0,00 % | Seelos: Phase 2/3 HEALEY ALS Trial Fails To Meet Statistical Significance In Endpoints | WASHINGTON (dpa-AFX) - Seelos Therapeutics, Inc. (SEEL) issued an update on top-line data of the Phase 2/3 HEALEY ALS Platform trial. The study was designed to evaluate SLS-005 in decreasing... ► Artikel lesen | |
| PLANTFUEL LIFE | 0,009 | 0,00 % | CSE Bulletin: Suspension - PlantFuel Life Inc. (FUEL) | Toronto, Ontario--(Newsfile Corp. - Le 3 avril/April 2024) - Effective immediately, PlantFuel Life Inc. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined... ► Artikel lesen | |
| MEDIPHARM LABS | 0,051 | -3,77 % | MediPharm Labs Corp.: MediPharm Labs Reports Fourth Quarter and Full Year Results | Annual Revenue and Adjusted EBITDA Improve by 50% TORONTO, March 27, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company")... ► Artikel lesen |
VITURA HEALTH LIMITED gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von +0,008 (+9,09 %) liegt der Kurs bei 0,096 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
